Columns Archive

Why U.S. Pressure Is Behind the Stalled Canadian Anti-Counterfeiting Bill

Appeared in the Toronto Star on August 30, 2104 as Why Dutch Guards Holding Indian-Made Drugs Bound for Nigeria Sends a Warning to Canadian Legislators Last year, the federal government trumpeted anti-counterfeiting legislation as a key priority in its Speech from the Throne. The bill raced through the legislative process […]

Read more ›

September 2, 2014 1 comment Columns Archive

What’s a ‘Reasonable Expectation’ of Privacy?

Appeared in the Toronto Star on August 23, 2014 as What’s a ‘Reasonable Expectation” of Privacy? Canadian privacy law has long been reliant on the principle of “reasonable expectation of privacy.”  The principle is particularly important with respect to the Charter of Rights and Freedoms, as the Supreme Court of […]

Read more ›

August 27, 2014 3 comments Columns Archive

How Canada Shaped the Copyright Rules in the EU Trade Deal

Appeared in the Toronto Star on August 16, 2014 as How Canada Shaped Copyright Rules in EU Trade Deal In late December 2009, Wikileaks, the website that publishes secret government information, posted a copy of the draft intellectual property chapter of the Canada – European Trade Agreement (CETA). The CETA […]

Read more ›

August 21, 2014 4 comments Columns Archive

Does Anyone Own a Country’s Domain Name?

Appeared in the Toronto Star on August 9, 2014 as Can Anyone Own a National Domain Name? Earlier this year, a group of U.S. litigants launched an unusual domain name lawsuit. The group consisted of family members of victims of terror attacks they claim were sponsored by the governments of […]

Read more ›

August 12, 2014 2 comments Columns Archive

How a 20 Year Old Patent Application Could Up-End Canada’s Biggest Trade Deal

Appeared in the Toronto Star on August 1, 2014 as How a 20 Year Old Patent Application Could Up-End Canada’s Biggest Trade Deal In the early 1990s, pharmaceutical giant Eli Lilly applied for patent protection in Canada for two chemical compounds, olanzapine and atomoxetine. The company had already obtained patents […]

Read more ›

August 5, 2014 3 comments Columns Archive